Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

OCX : 3.20 (+17.22%)
IMDX : 7.16 (-4.53%)
Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology

OCX : 3.20 (+17.22%)
OncoCyte: Q1 Earnings Snapshot

OncoCyte: Q1 Earnings Snapshot

OCX : 3.20 (+17.22%)
Oncocyte Reports Q1 2025 Results and Business Progress

OCX : 3.20 (+17.22%)
Oncocyte to Release First Quarter 2025 Results on May 12, 2025

OCX : 3.20 (+17.22%)
Best Momentum Stocks to Buy for May 6th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has a Zacks Rank #1 and witnessed...

OCX : 3.20 (+17.22%)
BYRN : 16.72 (-0.42%)
MAIA : 1.6000 (+4.58%)
Oncocyte Provides Positive Update on Clinical Trial Progress

OCX : 3.20 (+17.22%)
Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity

OCX : 3.20 (+17.22%)
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

OCX : 3.20 (+17.22%)
OncoCyte: Q4 Earnings Snapshot

OncoCyte: Q4 Earnings Snapshot

OCX : 3.20 (+17.22%)

Barchart Exclusives

3 Best Dividend Aristocrats to Buy in 2026
These Dividend Aristocrats have strong earnings growth, solid yields, and Wall Street buy ratings stand out as smart income plays for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar